enCore Energy ramps uranium production, posts gross profit but still reports net losses

enCore Energy Corp. (PINK: ENCUF) - Quick read on Q2 / H1 2025

Short summary: enCore is ramping uranium extraction (Alta Mesa and Rosita), producing positive gross margins in both the quarter and six‑month periods, but still reporting sizeable operating losses and a consolidated net loss attributable to shareholders. The company reduced some inventory and marketable securities positions, generated a one‑time realized securities gain, improved operating cash outflow vs prior year, yet faces legal claims, internal control weaknesses, related‑party debt and ongoing funding needs.

Key facts & statistics (from Form 10‑Q, amounts in thousands unless stated):
* Cash & cash equivalents: $26,897 (June 30, 2025) vs $39,701 (Dec 31, 2024).
* Restricted cash (performance bonds): $8,025 (June 30, 2025).
* Marketable securities (current): $11,357 (June 30, 2025) vs $24,046 (Dec 31, 2024).
* Inventory, net: $9,678 (June 30, 2025) vs $20,967 (Dec 31, 2024).
* Total current assets: $49,918; Total assets: $359,379 (June 30, 2025).
* Total liabilities: $64,460; Total equity: $294,919 (June 30, 2025).
* Non‑controlling interests: $30,243 (June 30, 2025).
* Revenue: Q2 2025 $3,664 (Q2 2024 $5,320); H1 2025 $21,904 (H1 2024 $35,714).
* Cost of sales: Q2 2025 $2,534 (Q2 2024 $10,428); H1 2025 $20,796 (H1 2024 $41,291).
* Gross profit (loss): Q2 2025 $1,130 vs (Q2 2024 $(5,108)); H1 2025 $1,108 vs (H1 2024 $(5,577)).
* Operating loss: Q2 2025 $(19,277) (Q2 2024 $(22,972)); H1 2025 $(34,903) (H1 2024 $(35,249)).
* Net loss attributable to enCore: Q2 2025 $(6,326) vs Q2 2024 $(22,019); H1 2025 $(30,569) vs H1 2024 $(29,301).
* Basic & diluted loss per share: Q2 2025 $(0.03); H1 2025 $(0.16).
* Uranium sales volumes: Q2 2025 60,000 lbs (Q2 2024 90,000 lbs); H1 2025 350,000 lbs (H1 2024 410,000 lbs).
* Realized average sales price: Q2 2025 $61.07/lb (Q2 2024 $59.11); H1 2025 $62.58/lb (H1 2024 $87.11).
* Cost per sold pound: Q2 2025 $42.23/lb (Q2 2024 $115.87); H1 2025 $59.42/lb (H1 2024 $100.71).
* Realized gain on marketable securities (sale of Anfield): $7,671 (recognized Q2 and H1 2025).
* Net cash used in operating activities (YTD): $(17,629) (H1 2024: $(40,117)).

Income statement - positives
* Gross profit returned to positive: Q2 gross profit $1,130 and H1 $1,108 - shows extraction and sales mix can be profitable before operating costs.
* Lower cost of sales per pound: cost applicable to revenues dropped materially (Q2 $42.23/lb; H1 $59.42/lb) - extraction and lower purchased inventory costs improved per‑pound economics.
* One‑time cash inflow from sale of marketable securities: realized gain $7,671 added to other income and provided proceeds (sale of 170M Anfield shares for CAD $19,550).
* Operating cash outflow improved vs prior year: H1 operating cash used $(17,629) vs $(40,117) in H1 2024 - working capital and inventory movements helped.

Income statement - negatives / pressures
* Large operating costs remain: total operating expenses Q2 2025 $20,407 and H1 $36,011 - G&A jumped (Q2 G&A $10,091 vs $5,025 last year) reflecting ramp and corporate growth.
* Company still loss‑making at the net level: H1 net loss attributable to shareholders $(30,569); Q2 loss improved but not eliminated $(6,326).
* Revenue declined year‑over‑year (H1 down 39%) driven by lower contracted sales volumes and lower realized average price H1 2025 $62.58/lb vs $87.11/lb in 2024.
* Volatility in marketable securities: unrealized loss on securities H1 2025 $(7,066) partly offset by the realized gain; market moves affect earnings.
* Interest / related‑party finance: note payable - related party principal $10,054 (June 30, 2025); Uranium Loan amendments (subsequent event) extend repayment and raise interest to 10% and add fees - financing costs and related‑party exposure remain risks.

Balance sheet & cash flow notes
* Cash down: $26.9M vs $39.7M at year‑end; working capital ~$30.2M (management cites this as available for near‑term needs).
* Inventory reduced to $9.7M from $21.0M - partly sold and impaired; remaining inventory 244,204 lbs at cost $9,678 per company schedules.
* Marketable securities decreased to $11.7M (from $24.9M) after sales and fair‑value movements.
* Capex / investment: P,P&E increased (net $31.7M) and intangible assets grew (data purchases now $1.334M) - company investing to ramp production.
* Financing activity in 2024 (Boss sale of 30% Alta Mesa for $60M) materially changed capital structure; 2025 financing inflows were much smaller (H1 financing cash provided $6.6M).
* Subsequent event: commitment letter to sell up to $15,000 of common shares (Aug 7, 2025) - new equity availability; Uranium Loan extended and Facility $3,600 available (Jul 2, 2025 amendment).

Operational & corporate highlights
* Alta Mesa ramp: uranium capture peaked at 3,705 lbs (June 20, 2025); first 22 days of June averaged 2,410 lbs/day = 53,022 lbs; May average 2,103 lbs/day - clear operational momentum.
* Drilling & wellfield expansion: 24 drill rigs across South Texas (25 active rigs as of June 30, 2025) to support ramp and resource replacement.
* Resource base (S‑K 1300): Measured & Indicated 30.94M lbs U3O8; Inferred 20.54M lbs U3O8 (company reported figures).

Risks, governance & other negatives to watch
* Legal claims: putative securities class action (filed Mar 14, 2025) and arbitration claims by former executives - outcome uncertain.
* Material weaknesses in internal controls (IT GITCs and process‑level controls) remain; remediation in progress but control risk persists.
* Full valuation allowance on deferred tax assets - no near‑term tax benefit recognized.
* Reliance on related‑party arrangements (Boss Energy) for uranium loan and JV financing; related‑party note payable was $10,054 at June 30, 2025.
* Commodity price and market risk: realized price per lb fell H1 year‑over‑year; company does not hedge uranium price exposure.

Bottom line
enCore is transitioning from restart/early production into a growth ramp - operationally the Alta Mesa and Rosita plants are delivering increasing extraction rates and gross margins are positive. However, the company remains loss‑making after operating expenses, has lower cash and marketable securities than a year ago, carries related‑party debt, faces legal and internal control headwinds, and will likely need continued access to capital (equity or facility) to fund further expansion. The realized Anfield gain and improved cash flow from operations are helpful near‑term, but monitor quarterly operating expense trends, the Uranium Loan amendments (cost/fees), remediation of internal controls, and any litigation outcomes.

Sources: enCore Energy Corp. Form 10‑Q for period ended June 30, 2025 (consolidated financial statements and MD&A).